Leukotrap Wb System
NDC Package 53157-736-92

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Leukotrap Wb System is a . Marketed by Haemonetics Manufacturing, this product is identified by NDC 53157-736 and is authorized under FDA application BN800077.

Identification & Billing

NDC Package Code
53157-736-92
Package Description
18 BAG in 1 CARTON / 63 mL in 1 BAG
Product Code
11-Digit Billing Format
53157073692

Clinical Specifications

Proprietary Name
Leukotrap Wb System
Dosage Form
-

Regulatory & Marketing

Labeler Name
Haemonetics Manufacturing
FDA Application #
BN800077
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
11-06-1980
End Marketing Date
10-31-2024
Listing Expiration
10-31-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (53157-736). Click a package code to view its specific billing and regulatory data.

18 BAG in 1 CARTON / 450 mL in 1 BAG
18 BAG in 1 CARTON / 63 mL in 1 BAG

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53157-736-92 identifies a specific commercial package of 18 bag in 1 carton / 63 ml in 1 bag of Leukotrap Wb System, labeled by Haemonetics Manufacturing. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Haemonetics Manufacturing on November 06, 1980. The current certification is valid through October 31, 2024.

How is this Haemonetics Manufacturing product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53157073692. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53157-736-92
11-Digit CMS (5-4-2)
53157-0736-92

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.